Member Info for HedgeHogarth

Spot on Ricky - feel free to remind the world every day :-)

And don't forget the GOLDEN RULE - whenever you see a post from NotPosting or Aldemoran - Ignore the Post and spend 2 minutes re-reading any of the 25 great RNS from Hemo in the last 12 months

Here they go again!

Aldermoran already trying their hardest to create FUD. Pretending to be a LTH - and then tryinh to suggest that the SP will go below £5.

The truth is this...

1. These warrants WILL be exercised at some point - share price is £9, exercise prices below £5.

2. Everything about the warrants is in the public domain - we all know they were issues, we all know the exercise price

3. The conversion of warrants will generate additional cash for Hemogenyx - c£1.5m

Yet another pathetic attempt, another waste of time, another post evidencing your manipulative agenda.

Lets hope that you get job satisfaction..... Vlad does in droves

For me - it just goes to show how stupid it is using charts to make investment decisions

The more relevent price for close were asscoaited with these two trades:

12-Nov-25 16:37:35 902.00 1,500 Unknown* 874.00 900.00 13.53k O

12-Nov-25 16:29:57 915.00 2,248 Unknown* 874.00 900.00 20.57k O

Ode to our unwanted guests....

i'd trade the truth for some lies sometimes

i feel better not knowing whats going on

no one else cares enough

so i will

be careful for all of us

how was i supposed to know

how was i supposed to know

Aldermoran and NotPosting are still in Overdrive - they will counter every credible, genuine post on here

They are filling up the forum with their fabrication and FUD

They are trying to distract Joe Public from the wonderful opportunity here.

Do yourself a favour, everytime they post, go and re-read the RNS list and ignore their fluff

You have ZERO insight or idea on what had come from the conferences (Other than the Estonia opportunity)

1) They may well have been investment from some who attended

2) There may well be conversations going with between interested parties - it is not normal to be told about them at this stage

You appear to be a bit 'green' when it comes to the ways business works

Three cheers for Vlad and Hemogenyx

If the traders are whinging they dont have the specifc timelines to help them trade this share price - then I for one support Vlad

It is not there job handhold the traders - it is their job to save lives and as a LTHer I feel like I have everything I need to know in terms of next steps

The FACTS

Hemo have issued 25 RNS business updates in the last 12mths (excluding ones relating to placings / conversions / voting rights)

Avacta have issued 22 ins the last 12mths - and I have been generous in some of those in included (excluding ones relating to placings / conversions / voting rights)

Saga (One of the UK's best performing small caps in last 12month) 'less than 10' RNS business updates

So it is simply LIES to suggest that Hemo do not update the market regularly

And addressing the placings and warrants. Hemo are a pre revenue Biotech - Biotechs need to raise (FACT) and Hemo have managed to do that successfully through one of the most credit queezed periods of the last 50 years. Pretty good achievement. They have survived the lows and in the coming months i expect them to be rewarded with new HIGHS

Wow - quite a lot to take in there JHFH!!!! Thanks for sharing

I have no doubt that you will now face a barrage from NotPosting and Alderbaron.- simply because you are let truth get in the way of their efforts to create fear, uncertainty etc

As you say, as a LTHer, I have no interest in selling my shares. Why would I sell when the company is at such a pivotal point in the life of a Biotech. All the signs suggest that CAR-T is working (FDA clearance and the comments Vlad has made in the RNS)

I did not see the move from sub £2 per share to £17 coming. I have long argued that the share was undervalued significantly but had no idea when the re-rate would kick in or how how it would go. I do have a view on what the potenial share price could look like - i.e. trying dividing anything between £200m and £500m across somehwere between 6 and 7 million shared - reflecting warrants, options etc )

Dec 2024 - Key milestone achieved - announce 1st clincial trial approved for CAR-T

Jan 2025 - First human patient injected with CAR-T - initial results proving the safety profile and encouraging efficacy.

Candidate potentially represents a transformational therapeutic for patients

What happens next?

The Answer:

Company acquired for a total consideration of up to $1,000m, on a cash and debt free basis. (initial payment of $425m on deal closing, and up to $575m in contingent consideration based on development and regulatory milestones)

Whilst the top of this post looks like I was talking about Hemogenyx - I was actually describing the compamy EsoBiotec.

EsoBiotec was bought due to the early results in Phase 1 and the fac that their candidate offerened something better for patients than the current available options.

Whilst CAR-T has proved groundbreaking and successful agasint some Cancers and conditions - finding a successful CAR-T solution for AML has proved elusive. That is why the progress made by Hemogenyx is so exciting and why the share price increased so agressively. NOTHING HAD CHANGED

Don't foget that Hemogenyx also have 2 other clincial candidates in CBR and CDX which arguably makes them even more attractive to Big Pharma. CBR in particular has incredible potential - the RNS updates are there to see. (e.g. Biodefense opportunity, potentially capable of curing all virus types known to man, potential to be off the shelf, considered to be unique and Hemo have secured Patents)

I cannot see any reason why the Hemogenyx story will not end in the same way as EsoBiotec.

Ignore all the rubbish and fabrication from the resident parasites - The future looks very bright for Hemogenyx

Good luck all

Beware of fallling into the trap of Alderbaron

He is here all day all day and everyday for ONE reason only - to talk down the company and try and undermine any positive sentiment

Why?

Because he stands to make money if the share price goes down.

He is no different to a trader who will say the share price is going to the moon - both will create a narrative that they hope will make them money

Pretty much everyone on this forum recognises the huge potential value in this share - the compay is undervalued today and if things continue to go well, the company's value could be at multiples of today's sub £50m mCAP. This could quite easily 10 bag in the next 12 months - there are a number of potential triggers - the most obvious being some sort of commercial deal - but further trial results and potential opportunities at key conferences could also create a spike

Alderbaran

Please explain what you mean by the following:

"You dont need to be Roy Walker to say what you see. Price has popped and now...

Without news, well, you know"

What do you mean price has popped - why has the share price gone up almost 20% in a few days? I assume you have a strong view if you think you know what happens next?

My experience is that there is never smoke without fire - share prices are driven by supply and demand. The price rise must be due to a demand for shares and/or a lack of supply of shares.

There you go - I say what I see.

Nice to see a blue day

Would. It surprise me if an RNS is around the corner - it would not be the first time we see the share price spring into action when an RNS is imminent.

Or maybe HEMO have had the green light for ASH and those that have reviewed their application have bought in?

Thanks Mr India

Great update - really exciting times

Vlad was very clear - he is looking for investment - he is looking for non-dilutive investment - a very positive sign for all invested

51 HEMO Posts and counting in the last 2 days from the resident parasites...

- 31 from 'Notposting' - desperation personified

- 20 from 'Alderbaron'

49 HEMO Posts and counting in the last 2 days from the resident parasites...

- 29 from 'Notposting' (another to add to the list)

He even has the temerity to include himeself in 'we'. Assume he means his group of parasites or multiple identidies on here. He certainly cannot included himself in a group of shareholders

- 20 from 'Alderbaron'

48 HEMO Posts and counting in the last 2 days from the resident parasites...

- 28 from 'Notposting' (up 3 on the last count - still nothing worth reading)

- 20 from 'Alderbaron'

Oh look - another fruitcake comes to the party

What an idiot - it hit £10 this month, in fact it hit £17

Saint - it is not all about the share price.

As we are seeing right the SP movements are not always In sync with progress and value.

I am talking more broadly - about the company and the progress being made. It's been amazing

45 HEMO Posts and counting in the last 2 days...

- 25 from 'Notposting'

- 20 from 'Alderbaron'

Even chatgpt will run out of fabricated shight for them to post soon

@Saint - I disagree strongly - HEMO treated the 1st patient in February - Its been an outstanding year. Throw in the successful raises, attendance at exclusive DCNY summit, FDA approval for peadiatric use, Letter of Intent, Manufactuyring partnership with Made Scientific, ongoing Phase 1 results

LOL @patheric excuse from Alderbaron - "I posted here after watching Vlads interview. Just because I have a different view on what was presented or should I say not presented, than you lot and dont end my post with go hemo go im attacked"

What's his pathetic excuse for the other 107 (ONE HUNDRED AND SEVEN) posts in the last 30 days

WHat kind of fruitcakes spend their life posting on a public forum of a company they constantly critisize and want to have a debate with LTHers. And why just HEMO? Are they daring to suggest they don't want to so the same with all the other companies?

These two clowns are PATHETIC

The good news for investors is that they are here because they know how undervalued the company is and are trying to make money in their own devious way. Sadly, that is at the expense of honest Private Investors who are affected by their actions

We have 'Aldebaron' and 'Notposting' spending many hour and posting many hundreds of messages on the Hemogenyx board

Why?

They appear to have both claimed that Hemo has huge potential and is massively undervalued - yet at the same time they spend their sad lives on here day in, day out spready fear, uncertainty and doubt.....

Hemogenyx has proved highly volatile - it recently hit a record mCAP of >£80m having 10-bagged from a sub £10m mCAP

Feel free to do your own research on Biotech valuations. My research suggest that HEMO should comfortably command an mcAP of £50-£100m based on its Pipeline, Assets, and near term opportunities.

I wonder how much these two parasites have made out of Hemo - or lost? Anyone trading Hemo genuinely risks missing the boat.

2025 has been an outstanding year for Hemogenyx and still time to build on that. I would not bet against Hemo making 2026 even more remarkable.